Cargando…
The Challenge of Managing Parkinson’s Disease Patients during the COVID-19 Pandemic
The 2019 novel coronavirus (nCoV) pandemic is rapidly developing across the globe and new information is emerging expeditiously and constantly, particularly in relation to neurological illnesses. Both central and peripheral nervous system involvement has been reported including headache, dizziness,...
Autores principales: | Garg, Divyani, Dhamija, Rajinder K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213030/ https://www.ncbi.nlm.nih.gov/pubmed/32419750 http://dx.doi.org/10.4103/aian.AIAN_295_20 |
Ejemplares similares
-
Teleneurorehabilitation for Parkinson’s Disease: A Panacea for the Times to Come?
por: Garg, Divyani, et al.
Publicado: (2020) -
Neuropalliative Care in India – Barriers, Challenges and Future Directions
por: Baruah, Upasana, et al.
Publicado: (2023) -
Disease-Modifying Therapy in Subacute Sclerosing Panencephalitis: An Area of Darkness
por: Garg, Divyani, et al.
Publicado: (2023) -
Uptake of telehealth in Parkinson's disease clinical care and research during the COVID-19 pandemic
por: Shivkumar, Vikram, et al.
Publicado: (2021) -
Consensus Statement on Neurorehabilitation during COVID-19 Times: Expert Group on Behalf of the Indian Federation of Neurorehabilitation (IFNR)
por: Dhamija, Rajinder K., et al.
Publicado: (2021)